At 24 weeks, 17 of 19 patients (89%) achieved varying levels of repigmentation. Patients were treated with tacrolimus 0.03% or 0.1% ointment for at least 3 months. Overall, 84% of the children responded at least partially to therapy. Of the 48 children placed on twice daily application regimens, 41 responded (85%).